sleep number corp. - SNBR
SNBR
Close Chg Chg %
10.07 -0.52 -5.16%
Closed Market
9.55
-0.52 (5.16%)
Volume: 453.20K
Last Updated:
Jun 4, 2025, 4:00 PM EDT
Company Overview: sleep number corp. - SNBR
SNBR Key Data
| Open $10.10 | Day Range 9.44 - 10.10 |
| 52 Week Range 4.48 - 20.75 | Market Cap $228.19M |
| Shares Outstanding 22.66M | Public Float 18.63M |
| Beta 1.87 | Rev. Per Employee N/A |
| P/E Ratio N/A | EPS -$0.95 |
| Yield 0.00% | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME 556.48K |
SNBR Performance
| 1 Week | -11.25% | ||
| 1 Month | 33.94% | ||
| 3 Months | 26.16% | ||
| 1 Year | -33.31% | ||
| 5 Years | -75.88% |
SNBR Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
4
Full Ratings ➔
About sleep number corp. - SNBR
Sleep Number Corp. engages in the design, manufacture, marketing, and distribution of beds, proprietary beds, and other sleep-related accessory products. It offers beds under the brand name Sleep Number. The company was founded by Robert Walker and JoAnn Walker in 1987 and is headquartered in Minneapolis, MN.
SNBR At a Glance
Sleep Number Corp.
1001 Third Avenue South
Minneapolis, Minnesota 55404
| Phone | 1-763-551-7000 | Revenue | 1.68B | |
| Industry | Home Furnishings | Net Income | -20,334,000.00 | |
| Sector | Consumer Durables | Employees | 3,654 | |
| Fiscal Year-end | 12 / 2025 | |||
| View SEC Filings |
SNBR Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 0.205 |
| Price to Book Ratio | N/A |
| Price to Cash Flow Ratio | 12.718 |
| Enterprise Value to EBITDA | 12.054 |
| Enterprise Value to Sales | 0.76 |
| Total Debt to Enterprise Value | 0.732 |
SNBR Efficiency
| Revenue/Employee | 460,398.467 |
| Income Per Employee | -5,564.86 |
| Receivables Turnover | 35.29 |
| Total Asset Turnover | 1.626 |
SNBR Liquidity
| Current Ratio | 0.20 |
| Quick Ratio | 0.086 |
| Cash Ratio | 0.002 |
SNBR Profitability
| Gross Margin | 59.607 |
| Operating Margin | 2.433 |
| Pretax Margin | -1.516 |
| Net Margin | -1.209 |
| Return on Assets | -1.966 |
| Return on Equity | N/A |
| Return on Total Capital | -4.197 |
| Return on Invested Capital | N/A |
SNBR Capital Structure
| Total Debt to Total Equity | N/A |
| Total Debt to Total Capital | 193.202 |
| Total Debt to Total Assets | 95.596 |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | 63.403 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Sleep Number Corp. - SNBR
Collapse All in section
| All values USD millions. | 2021 | 2022 | 2023 | 2024 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 2.18B | 2.11B | 1.89B | 1.68B | |
Sales Growth
| +17.69% | -3.23% | -10.73% | -10.87% | |
Cost of Goods Sold (COGS) incl D&A
| 866.10M | 912.00M | 783.01M | 679.52M | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 60.39M | 67.40M | 72.40M | 65.20M | |
Depreciation
| 58.19M | 65.20M | 71.00M | 65.00M | |
Amortization of Intangibles
| 2.20M | 2.20M | 1.40M | 200.00K | |
COGS Growth
| +23.63% | +5.30% | -14.14% | -13.22% | |
Gross Income
| 1.32B | 1.20B | 1.10B | 1.00B | |
Gross Income Growth
| +14.09% | -8.84% | -8.14% | -9.21% | |
Gross Profit Margin
| +60.36% | +56.87% | +58.52% | +59.61% |
| 2021 | 2022 | 2023 | 2024 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 1.13B | 1.13B | 1.07B | 961.84M | |
Research & Development
| 58.54M | 61.52M | 55.80M | 45.26M | |
Other SG&A
| 1.07B | 1.07B | 1.01B | 916.58M | |
SGA Growth
| +15.88% | +0.81% | -6.05% | -9.75% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| - | - | 15.73M | 18.07M | - |
EBIT after Unusual Expense
| 193.54M | 67.88M | 22.94M | 22.87M | |
Non Operating Income/Expense
| - | - | - | - | - |
Non-Operating Interest Income
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| 6.25M | 18.98M | 42.70M | 48.37M | |
Interest Expense Growth
| -30.02% | +204.00% | +124.89% | +13.29% | |
Gross Interest Expense
| 6.25M | 18.98M | 42.70M | 48.37M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| 187.29M | 48.90M | (19.75M) | (25.50M) | |
Pretax Income Growth
| +6.43% | -73.89% | -140.40% | -29.07% | |
Pretax Margin
| +8.57% | +2.31% | -1.05% | -1.52% | |
Income Tax
| 33.55M | 12.29M | (4.47M) | (5.16M) | |
Income Tax - Current - Domestic
| 21.59M | 20.69M | 8.58M | 8.16M | |
Income Tax - Current - Foreign
| - | - | - | - | - |
Income Tax - Deferred - Domestic
| 11.96M | (8.41M) | (13.05M) | (13.32M) | |
Income Tax - Deferred - Foreign
| - | - | - | - | - |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| 153.75M | 36.61M | (15.29M) | (20.33M) | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| 153.75M | 36.61M | (15.29M) | (20.33M) | |
Net Income Growth
| +10.46% | -76.19% | -141.76% | -33.01% | |
Net Margin Growth
| +7.04% | +1.73% | -0.81% | -1.21% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| 153.75M | 36.61M | (15.29M) | (20.33M) | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 153.75M | 36.61M | (15.29M) | (20.33M) | |
EPS (Basic)
| 6.396 | 1.6347 | -0.6816 | -0.8995 | |
EPS (Basic) Growth
| +27.13% | -74.44% | -141.70% | -31.97% | |
Basic Shares Outstanding
| 24.04M | 22.40M | 22.43M | 22.61M | |
EPS (Diluted)
| 6.1629 | 1.602 | -0.6816 | -0.8995 | |
EPS (Diluted) Growth
| +25.87% | -74.01% | -142.55% | -31.97% | |
Diluted Shares Outstanding
| 24.95M | 22.85M | 22.43M | 22.61M | |
EBITDA
| 253.93M | 135.28M | 111.07M | 106.14M | |
EBITDA Growth
| +3.03% | -46.73% | -17.90% | -4.44% | |
EBITDA Margin
| +11.62% | +6.40% | +5.88% | +6.31% |
Snapshot
| Average Recommendation | HOLD | Average Target Price | 8.333 | |
| Number of Ratings | 4 | Current Quarters Estimate | -0.107 | |
| FY Report Date | 06 / 2025 | Current Year's Estimate | -0.383 | |
| Last Quarter’s Earnings | -0.38 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | -0.90 | Next Fiscal Year Estimate | 0.374 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 4 | 4 | 4 | 4 |
| Mean Estimate | -0.11 | 0.09 | -0.38 | 0.37 |
| High Estimates | 0.00 | 0.34 | 0.01 | 0.66 |
| Low Estimate | -0.19 | -0.10 | -1.00 | 0.00 |
| Coefficient of Variance | -83.31 | 223.57 | -123.80 | 79.26 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 0 | 0 | 0 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 4 | 4 | 5 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Hold | Hold | Hold |
SEC Filings for Sleep Number Corp. - SNBR
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Sleep Number Corp. - SNBR
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Jun 3, 2025 | Shelly Radue Ibach | 30,800 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $10.76 per share | 331,408.00 |
| Jun 3, 2025 | Shelly Radue Ibach | N/A | Bona fide gift | 0.00 |
| Jun 3, 2025 | Shelly Radue Ibach | 426,849 | Bona fide gift | 0.00 |
| Jun 3, 2025 | Andrea L. Bloomquist | 92,445 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $10.76 per share | 994,708.20 |
| Apr 18, 2025 | Linda Findley Kozlowski President and CEO | 181,029 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 18, 2025 | Linda Findley Kozlowski President and CEO | 543,086 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 18, 2025 | Joel Laing Treasurer & CAO | 15,798 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $5.03 per share | 79,463.94 |
| Mar 14, 2025 | Gary T. Fazio | 71,125 | Open market or private purchase of non-derivative security Non-derivative transaction at $7.54 per share | 536,282.50 |
| Feb 26, 2025 | Patrick A. Hopf | 75,000 | Open market or private purchase of non-derivative security Non-derivative transaction at $14.3 per share | 1,072,500.00 |
| Nov 8, 2024 | Stadium Capital Management LLC | 2,093,914 | Open market or private purchase of non-derivative security Non-derivative transaction at $13.53 per share | 28,330,656.42 |
| Nov 8, 2024 | Stadium Capital Management LLC | 2,094,275 | Open market or private purchase of non-derivative security Non-derivative transaction at $14.15 per share | 29,633,991.25 |
| Nov 8, 2024 | Stadium Capital Management LLC | 2,094,375 | Open market or private purchase of non-derivative security Non-derivative transaction at $15 per share | 31,415,625.00 |
| Nov 8, 2024 | Stadium Capital Management LLC | 2,094,675 | Open market or private purchase of non-derivative security Non-derivative transaction at $13.94 per share | 29,199,769.50 |
| Aug 9, 2024 | Stephen E. Macadam Director | 102,729 | Open market or private purchase of non-derivative security Non-derivative transaction at $12.35 per share | 1,268,703.15 |